Literature DB >> 19777314

Initial experience with new intraluminal devices for GERD, Barrett's esophagus, and obesity.

Charles J Filipi1, Rudolf J Stadlhuber.   

Abstract

BACKGROUND: Transoral intraluminal surgery is less painful. However, endoscopic antireflux procedures have been unsuccessful, endoscopic foregut mucosal excision procedures are often difficult to perform, and endoscopic intra-luminal suturing is both imprecise and too shallow. We have endeavored to correct these deficiencies and report here new devices for GERD, obesity, and Barrett's mucosal excision.
METHOD: A retrospective review of ex vivo and in vivo animal experiments using sharp blade mucosal excision for esophageal and gastric mucosa and a suturing device with transverse needles designed to full thickness penetrate the gastric wall were completed. A total of 338 excisions were performed in 134 ex vivo tissue experiments and in 119 in vivo attempts. Suture needle testing was performed in ex vivo human stomachs and porcine stomachs and in in vivo canine and baboon stomachs.
RESULTS: One excision perforation (0.9%) occurred in a live animal. Satisfactory mucosal excision depth for the Barrett's device was reproducible. Progressive suture actuation reliability improved from 83% during ex vivo testing to 96.7% in in vivo experiments.
CONCLUSION: The results demonstrate feasibility, reliability, and safety for gastric and esophageal mucosal excision. Suturing reliability improved and further studies will be performed to finalize the instrument designs, the operative techniques, and the other device applications.

Entities:  

Mesh:

Year:  2009        PMID: 19777314     DOI: 10.1007/s11605-009-1027-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  20 in total

1.  Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients.

Authors:  B F Overholt; M Panjehpour; J M Haydek
Journal:  Gastrointest Endosc       Date:  1999-01       Impact factor: 9.427

2.  Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy.

Authors:  J J Nigro; J A Hagen; T R DeMeester; S R DeMeester; J Theisen; J H Peters; M Kiyabu
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

3.  Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus.

Authors:  C G Montes; N A Brandalise; R Deliza; A F Novais de Magalhães; J G Ferraz
Journal:  Gastrointest Endosc       Date:  1999-08       Impact factor: 9.427

4.  Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial.

Authors:  M P Schwartz; H Wellink; H G Gooszen; J M Conchillo; M Samsom; A J P M Smout
Journal:  Gut       Date:  2006-06-08       Impact factor: 23.059

5.  Endoscopic ablation of Barrett's esophagus using argon plasma coagulation (APC) following surgical laparoscopic fundoplication.

Authors:  M Morino; F Rebecchi; C Giaccone; S Taraglio; L Sidoli; R Ferraris
Journal:  Surg Endosc       Date:  2003-02-17       Impact factor: 4.584

6.  Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study.

Authors:  C Moreno; J Closset; S Dugardeyn; M Baréa; A Mehdi; L Collignon; M Zalcman; M Baurain; O Le Moine; J Devière
Journal:  Endoscopy       Date:  2008-05       Impact factor: 10.093

7.  Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device.

Authors:  Blair A Jobe; Robert W O'Rourke; Barry P McMahon; Flemming Gravesen; Cedric Lorenzo; John G Hunter; Mary Bronner; Stefan J M Kraemer
Journal:  Ann Surg       Date:  2008-07       Impact factor: 12.969

8.  KTP laser ablation of Barrett's esophagus after anti-reflux surgery results in long-term loss of intestinal metaplasia. Potassium-titanyl-phosphate.

Authors:  S P Bowers; S G Mattar; P J Waring; K Galloway; A Nasir; R Pascal; J G Hunter; S G Mattear
Journal:  Surg Endosc       Date:  2002-10-08       Impact factor: 4.584

Review 9.  Endoscopic therapy of gastroesophageal reflux disease: outcomes of the randomized-controlled trials done to date.

Authors:  Richard I Rothstein
Journal:  J Clin Gastroenterol       Date:  2008 May-Jun       Impact factor: 3.062

10.  Safety, feasibility and weight loss after transoral gastroplasty: First human multicenter study.

Authors:  J Devière; G Ojeda Valdes; L Cuevas Herrera; J Closset; O Le Moine; P Eisendrath; C Moreno; S Dugardeyn; M Barea; R de la Torre; S Edmundowicz; S Scott
Journal:  Surg Endosc       Date:  2007-11-01       Impact factor: 4.584

View more
  2 in total

Review 1.  Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

Authors:  Katsuhiko Iwakiri; Yoshikazu Kinoshita; Yasuki Habu; Tadayuki Oshima; Noriaki Manabe; Yasuhiro Fujiwara; Akihito Nagahara; Osamu Kawamura; Ryuichi Iwakiri; Soji Ozawa; Kiyoshi Ashida; Shuichi Ohara; Hideyuki Kashiwagi; Kyoichi Adachi; Kazuhide Higuchi; Hiroto Miwa; Kazuma Fujimoto; Motoyasu Kusano; Yoshio Hoshihara; Tatsuyuki Kawano; Ken Haruma; Michio Hongo; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-06-21       Impact factor: 7.527

2.  Transoral mucosal excision sutured gastroplasty: a pilot study for GERD and obesity with two-year follow-up.

Authors:  Andras Legner; Aron Altorjay; Arpad Juhasz; Rudolph Stadlhuber; Viktor Reich; Brandon Hunt; Richard Rothstein; Charles Filipi
Journal:  Surg Innov       Date:  2014-03-12       Impact factor: 2.058

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.